Literature DB >> 29055558

Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.

Kasumi Yamamoto1, Shoji Nagao2, Kazuhiro Suzuki1, Ai Kogiku1, Tokihiro Senda1, Hiroko Yano1, Miho Kitai1, Takaya Shiozaki1, Kazuko Matsuoka1, Satoshi Yamaguchi1.   

Abstract

OBJECTIVES: This study clarified the incidence of and identified the risk factors for post-radiation pelvic insufficiency fractures (PIFs) in women who received postoperative definitive or adjuvant radiotherapy (RT) for cervical cancer. PATIENTS AND METHODS: The medical records and data of imaging studies, including computed tomography scan and magnetic resonance imaging, of women with cervical cancer who received external-beam RT for the entire pelvic area between January 2003 and December 2012 at our institution were reviewed.
RESULTS: A total of 533 patients with histologically diagnosed cervical cancer who received RT (298: definitive RT, 235: adjuvant RT) were included in this study. Eighty-four patients (15.8%) developed PIF in the irradiated field. Median age at onset of PIF was 72.5years (range: 54-95years), and 82 of them (98%) were postmenopausal women. Sixty-nine patients (80%) developed PIF within 3years from the completion of RT. The median time for the development of PIF was 14months (range: 1-81months). The most commonly involved fracture site was the sacral bone. Postmenopausal state, coexistence of rheumatoid arthritis, and high-dose-rate intracavitary brachytherapy (HDR-ICBT) use were significant predisposing factors for the development of PIF, according to multivariate analysis.
CONCLUSIONS: The incidence rate of PIF among patients who received RT for locally advanced cervical cancer was 15.8%. The principal predisposing factors for post-radiation PIF were postmenopausal state, rheumatoid arthritis, and HDR-ICBT use. Active interventions, including bone density screening followed by medication, should be considered during the early stage of RT for women with high-risk factors of PIF.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Cervical cancer; Pelvic insufficiency fractures; Radiation therapy

Mesh:

Year:  2017        PMID: 29055558     DOI: 10.1016/j.ygyno.2017.09.035

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.

Authors:  Mila P Salcedo; Anil K Sood; Anuja Jhingran; Patricia J Eifel; Ann H Klopp; Revathy B Iyer; Bryan M Fellman; Camilo Jimenez; Kathleen M Schmeler
Journal:  Cancer       Date:  2020-03-03       Impact factor: 6.860

2.  Pelvic Insufficiency Fractures in Cervical Cancer After Radiation Therapy: A Meta-Analysis and Review.

Authors:  Youn Kyung Chung; Young-Kyun Lee; Byung-Ho Yoon; Dong Hoon Suh; Kyung-Hoi Koo
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  Dose optimization strategy of sacrum limitation in cervical cancer intensity modulation radiation therapy planning.

Authors:  Qi Guo; Shang Cai; Jianjun Qian; Ye Tian
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  Attention to bone health in follow-up of gynaecological cancers in tertiary care.

Authors:  Catherine A O'Gorman; Sorcha Minnock; Joseph Mulhall; Noreen Gleeson
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

5.  Radiation-induced occult insufficiency fracture or bone metastasis after radiotherapy for cervical cancer? The nomogram based on quantitative apparent diffusion coefficients for discrimination.

Authors:  Xi Zhong; Huali Jiang; Hui Mai; Jialin Xiang; Jiansheng Li; Zhiqing Huang; Songxin Wu; Liangping Luo; Kuiming Jiang
Journal:  Cancer Imaging       Date:  2020-10-23       Impact factor: 3.909

6.  Predictive factors of posttreatment fracture by definitive radiotherapy for uterine cervical cancer.

Authors:  Kazuki Ishikawa; Tsuneo Yamashiro; Takuro Ariga; Takafumi Toita; Wataru Kudaka; Joichi Heianna; Hitoshi Maemoto; Takeaki Kusada; Wataru Makino; Yoichi Aoki; Sadayuki Murayama
Journal:  Jpn J Radiol       Date:  2020-09-07       Impact factor: 2.374

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.